301075 多瑞醫藥
按盤價 
20.410 +0.410 (+2.050%)
20.410 +0.410 (+2.050%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.283 | 2.475 | 2.655 | 13.235 | 46.845 |
| 總資產報酬率 ROA (%) | -1.594 | 1.913 | 2.343 | 11.208 | 27.655 |
| 投入資產回報率 ROIC (%) | -1.773 | 2.074 | 2.449 | 12.454 | 39.273 | 邊際利潤分析 |
| 銷售毛利率 (%) | 40.753 | 68.552 | 76.981 | 88.608 | 90.944 |
| 營業利潤率 (%) | -12.832 | 6.637 | 5.300 | 13.860 | 20.757 |
| 息稅前利潤/營業總收入 (%) | -12.712 | 5.295 | 3.316 | 13.853 | 21.075 |
| 淨利潤/營業總收入 (%) | -13.245 | 5.113 | 4.634 | 12.436 | 18.282 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 124.962 | 16.708 | 59.917 | 86.991 | 63.876 |
| 價值變動淨收益/利潤總額(%) | -25.533 | 25.662 | 0.054 | -0.268 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 1.729 | 0.277 | -1.101 | -0.170 | -0.716 | 償債能力分析 |
| 流動比率 (X) | 4.604 | 5.024 | 4.478 | 11.611 | 1.830 |
| 速動比率 (X) | 4.154 | 4.767 | 4.252 | 11.455 | 1.717 |
| 資產負債率 (%) | 28.398 | 23.370 | 16.182 | 7.375 | 0.351 |
| 帶息債務/全部投入資本 (%) | 24.531 | 19.278 | 12.196 | 2.961 | 14.365 |
| 股東權益/帶息債務 (%) | 305.467 | 416.939 | 719.075 | 3,277.070 | 596.129 |
| 股東權益/負債合計 (%) | 238.260 | 308.101 | 516.675 | 1,262.815 | 186.027 |
| 利息保障倍數 (X) | -36.813 | -3.893 | -1.722 | 836.483 | 45.217 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 118.019 | 91.088 | 84.255 | 67.179 | 69.452 |
| 存貨周轉天數 (天) | 105.966 | 112.825 | 83.045 | 73.544 | 87.230 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/11/2024 14:34 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
